Ongoing Studies

CURRENTLY ENROLLING

Psoriasis

MedaPhase is evaluating the safety and effectiveness of a systemic injectable investigational medication, or placebo, for the treatment of Psoriasis.

You may be qualified to participate if you:

  • Are 18 years of age and older
  • Have at least 10% Body Surface Area Coverage
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

Wart

MedaPhase is evaluating the safety and effectiveness of a topical  investigational medication, or placebo, for the treatment of Warts.

You or your child may be qualified to participate if they:

  • Are 2 years of age and older
  • Have 1 – 6 warts on the trunk, or extremities.
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

Actinic Keratosis

MedaPhase is evaluating the safety and effectiveness of a topical  investigational medication, or placebo, for the treatment of Actinic Keratosis.

You  may be qualified to participate if you:

  • Are 18 years of age and older
  • Have at least 4 Actinic Keratosis on the face or scalp
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

Atopic Dermatitis (Eczema)

MedaPhase is evaluating the safety and effectiveness of a systemic investigational medication, or placebo, for the treatment of Atopic Dermatitis (Eczema)

You may be qualified to participate if you:

  • Are 18 years of age and older
  • Have at least 10% Body Surface Area Coverage
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

Atopic Dermatitis

MedaPhase is evaluating the safety and effectiveness of a topical  investigational medication,  for the treatment of Atopic Dermatitis (Eczema).

You or your child may be qualified to participate if they:

  • Are 2 years of age and older
  • Have 2% Body Surface Area Coverage
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

Prurigo Nodularis

MedaPhase is evaluating the safety and effectiveness of an oral  investigational medication, or placebo, for the treatment of Prurigo Nodularis

You may be qualified to participate if you:

  • Are 18 years of age and older
  • Have at least 10 Prurigo Nodularis
  • Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

REGISTER FOR AN ONGOING STUDY

We’re conducting studies in a variety of areas. If you’re interested in participating fill out the form below or click the indication to learn more.

Full Name*

Email*

Phone Number*

Zip Code*

Preferred method of contact: PhoneEmail

Check the skin conditions that apply to you:
AcneActinic KeratosisAtopic DermatitisEczemaMolluscumMale Pattern Hair LossOnychomycosisPsoriasisRosaceaSkin CancerWartsOther

Message: